Advertisement

Hospital pharmacy news, drug costs and specialty pharmacy trends

Becker’s reports on drug prices, shortages and the specialty pharmacy programs health systems are building. Coverage extends to 340B policy, pharmacy staffing and the distribution models.



More in Pharmacy

Workers’ compensation claims with drugs dispensed through home delivery pharmacies had prescription payments seven times larger than claims with drugs dispensed only through retail pharmacies, according to a study from the Workers Compensation Research Institute released Nov. 17. Here are…

Viatris has completed its acquisition of Pacira BioSciences, a non-opioid pain management company. The transaction closed Nov. 17, after Viatris accepted for payment approximately 32,929,780 shares, representing approximately 66.46% of Pacira’s outstanding stock, tendered at $36.50 per share in cash.…

The FDA granted accelerated approval to Nuvalent’s Nelkarmi (neladalkib) Nov. 17 for adults with previously treated, locally advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. The kinase inhibitor is approved for patients who previously received alectinib as…

Author’s note: The concepts described herein are intended as a strategic framework rather than a prescriptive operating model. Health systems vary in structure, clinical capabilities, financial models, technology, market characteristics and local operating environments. These factors should be considered when…

UnitedHealth Group’s pharmacy benefit manager, Optum Rx, has launched three digital tools for members, building on its model designed for more transparency announced earlier in 2026. According to a Nov. 17 post, Shop MyScript alerts members of savings opportunities soon…

Maryland’s Prescription Drug Affordability Board voted unanimously Nov. 16 to approve final regulations setting upper payment limits on Novo Nordisk’s Ozempic and Boehringer Ingelheim’s Jardiance, the first state payment limits on either drug, according to the Baltimore Sun. The limits…

From the ICU to the primary care office to central distribution centers, health systems are rethinking where pharmacy work happens. Here are five moves from recent weeks:

When the FDA approved daraxonrasib for metastatic pancreatic cancer Aug. 26, some in oncology expected access to remain concentrated at academic medical centers. Nearly three months later, leaders at seven organizations say patients at many cancer centers, including community sites,…

Erica Diamantides, PharmD, has been appointed vice president and chief pharmacy officer at Boston-based Tufts Medicine, according to a Nov. 16 LinkedIn post. Dr. Diamantides was most recently vice president of ambulatory pharmacy at Tufts Medicine, a role she held…

Advertisement
Advertisement
Advertisement